Mirtazapine Does Not Decrease Blood Pressure
Mirtazapine (Remeron) does not decrease blood pressure and has minimal to no clinically significant effects on blood pressure in most patients. According to the FDA label, analysis of vital signs including blood pressure showed that no changes occurred with mirtazapine treatment, with a pattern fully comparable to placebo 1. However, mirtazapine can rarely cause orthostatic hypotension, particularly in elderly patients or those with cardiovascular disease.
Blood Pressure Effects Profile
Neutral Blood Pressure Impact
- Clinical trial data demonstrates mirtazapine produces no significant changes in blood pressure compared to placebo 2
- The drug lacks adrenergic effects that would typically influence blood pressure 3
- Research confirms mirtazapine has minimal effects on blood pressure in long-term studies 3
Rare Orthostatic Hypotension Risk
The FDA label warns that mirtazapine may rarely lead to orthostatic hypotension, particularly in:
- Elderly patients
- Patients with pre-existing cardiovascular disease
- Those taking concomitant medications that affect blood pressure 1
This orthostatic effect is attributed to mirtazapine's antihistaminic (H1) properties at low doses 4, not a general blood pressure-lowering mechanism.
Clinical Context
Comparison to Other Antidepressants
Mirtazapine's neutral blood pressure profile distinguishes it from other antidepressants:
- SNRIs (particularly venlafaxine) carry greater risk of hypertension 3
- Tricyclic antidepressants are associated with both blood pressure increases and orthostatic hypotension 3
- MAOIs can cause orthostatic hypotension or hypertensive crisis 3
Cardiovascular Safety
Mirtazapine demonstrates no significant cardiovascular adverse effects at doses up to 22 times the maximum recommended dose 4. The drug is considered safe in overdose, with excessive somnolence being the only symptom reported 2, 5.
Important Caveats
Monitor for orthostatic symptoms when initiating mirtazapine, especially in:
- Patients ≥65 years old
- Those with history of cardiovascular disease
- Patients on antihypertensive medications
- Individuals with baseline orthostatic hypotension
The FDA label specifically notes to avoid concomitant use with benzodiazepines and alcohol, as these can increase impairment of cognitive and motor skills, potentially worsening fall risk in patients experiencing orthostatic changes 1.
Bottom Line
If you're considering mirtazapine for a patient with hypertension, do not expect blood pressure reduction. The drug is blood pressure-neutral in most patients. If your patient has hypotension or orthostatic symptoms, use caution and monitor closely, particularly during dose initiation and titration. For patients requiring both antidepressant therapy and blood pressure management, mirtazapine represents a safe option that won't interfere with antihypertensive treatment goals.